Bevacizumab Combined With Chemotherapy Prolongs Survival for Some Patients with Advanced Lung Cancer
Preliminary results from a large, randomized clinical trial for patients with previously untreated advanced non-squamous, non-small cell lung cancer show that those patients who received bevacizumab (Avastin™) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.
Clinical Trial of Gefitinib for Advanced Lung Cancer Closes Early
Researchers have closed a randomized clinical trial comparing gefitinib (Iressa) to a placebo following chemotherapy and radiation for patients with non-small cell lung cancer that had spread only to nearby tissues or lymph nodes. Review of the interim data indicated that gefitinib would not improve survival.
Post-Surgery Chemotherapy Improves Survival in Early Lung Cancer
Two large randomized studies show that in early-stage non-small cell lung cancer, treatment after surgery with chemotherapy improves overall survival compared to surgery alone. The findings help resolve a controversy over the value of post-surgical chemotherapy for early lung cancer and are likely to change the standard of care.
Biological Therapy
An introduction to biological therapy to help patients prepare to receive it for cancer treatment or managing side effects.
Lasers in Cancer Treatment
A fact sheet that describes use of high-intensity light in cancer treatment, its advantages and disadvantages, and types of procedures that use it.
Photodynamic Therapy for Cancer
A fact sheet that explains photodynamic therapy, how it is administered, and indications and side effects of treatment.
